OpenLobby.EU
Explore

Stichting Lygature

LYG

Our mission is to deliver breakthrough innovations in medical technology and drug development that address unmet medical needs by providing partnership management.

Lobbying Activity

Response to EU Life sciences strategy

16 Apr 2025

On behalf of Foundation Lygature, please find attached our response to call for evidence on A strategy for European life sciences. Although there are many factors important for a high performing ecosystem, weve focused our input on the Call for Evidence by the European Commission on those topics in which we have obtained significant experience over the past two decades. Were passionate about building and driving collaborations between all relevant stakeholders including academia, industry and society to achieve goals that no single party can achieve on its own. By leading and supporting these types of partnerships, and mobilizing our network and expertise, we ensure that these initiatives not only achieve their intended outcomes but also drive paradigm shifts in these fields, strengthening the overall healthcare innovation ecosystem. The European Commission has a crucial role in developing an overarching long-term vision for the Life Sciences Ecosystem and the responsibility to provide the best fit-for-purpose framework and toolbox to let the ecosystem thrive in order to create health and wealth. Not just to benefit the European citizens but to create a steady flow of positive impact worldwide. At Lygature were ready to continue working with the Commission, to provide input, to share our expertise and to provide hands-on contributions in generating the much needed impact each and every day.
Read full response